Page last updated: 2024-12-05

ethyl methanesulfonate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ethyl Methanesulfonate: An antineoplastic agent with alkylating properties. It also acts as a mutagen by damaging DNA and is used experimentally for that effect. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ethyl methanesulfonate : A methanesulfonate ester resulting from the formal condensation of methanesulfonic acid with ethanol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6113
CHEMBL ID338686
CHEBI ID23994
SCHEMBL ID2296
MeSH IDM0007896

Synonyms (75)

Synonym
smr001224511
MLS002152903
nsc-26805
EMS ,
ethyl ester of methanesulfonic acid
nsc26805
cb 1528
ethyl methanesulfonate
wln: ws1&o2
ethyl mesylate
methylsulfonic acid, ethyl ester
half-myleran
nsc 26805
methanesulfonic acid, ethyl ester
62-50-0
ethyl ester of methylsulfonic acid
NCI60_002168
ent 26,396
ethyl methane sulfonate
rcra waste number u119
NCGC00090890-01
ethyl methanesulphonate
ethylester kyseliny methansulfonove [czech]
einecs 200-536-7
rcra waste no. u119
hsdb 4007
ai3-26396
methanesulfonic acid ethyl ester
ethyl methansulphonate
ethyl ester of methylsulphonic acid
brn 0773969
ent 26396
ethyl ester of methanesulphonic acid
ccris 299
methanesulphonic acid ethyl ester
inchi=1/c3h8o3s/c1-3-6-7(2,4)5/h3h2,1-2h
ethyl methanesulfonate, liquid
chebi:23994 ,
CHEMBL338686
M0607
NCGC00090890-02
C19239
HMS3039D16
dtxsid6025309 ,
tox21_200006
cas-62-50-0
dtxcid705309
NCGC00257560-01
AKOS006221868
unii-9h154di0up
9h154di0up ,
ethylester kyseliny methansulfonove
FT-0628288
ethyl methanesulfonate [hsdb]
ethyl methanesulfonate [mi]
ethyl methanesulfonate [iarc]
SCHEMBL2296
methylsulfonic acid ethyl ester
ethyl methansulfonate
W-104993
ethyl methanesulfonate, certified reference material, tracecert(r)
mfcd00007559
ethyl methanesulfonate, 99%
ethyl methanesulfonate, >=98.0% (t)
DS-3245
Q416643
methanesulfonate ethyl
ethyl mesylate;methanesulfonic acid, ethyl ester
BCP34359
AMY38422
H10715
ethyl-d5 methanesulfonate
EN300-1238093
CS-W016570
HY-W015854

Research Excerpts

Overview

Ethyl methanesulfonate (EMS) is a mesylate ester, which is known to be a potent mutagen, teratogen, and possibly carcinogen. It has been found by Roche laboratories in nelfinavir mesylates, the active pharmaceutical ingredient of Viracept.

ExcerptReferenceRelevance
"Ethyl methanesulfonate (EMS) is an excellent mutagen that induces genome-wide efficient mutations to activate the mutagenic potential of plants with many advantages."( Ethyl methanesulfonate mutant library construction in Gossypium hirsutum L. for allotetraploid functional genomics and germplasm innovation.
Fan, Y; Gou, Z; Guo, H; Jiao, C; Li, T; Lian, X; Liu, Y; Tang, Z; Wu, J; Zeng, F; Zhang, C; Zhang, L, 2020
)
2.72
"Ethyl methanesulfonate (EMS) is a mesylate ester, which is known to be a potent mutagen, teratogen, and possibly carcinogen. "( Measurement of ethyl methanesulfonate in human plasma and breast milk samples using high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
Barr, DB; Davis, MD; Jayatilaka, NK; Kuklenyik, P; Montesano, MA; Needham, LL; Whitehead, RD, 2010
)
2.16
"Ethyl methanesulfonate (EMS) is a potential human mutagenic and carcinogenic compound which has been found by Roche laboratories in nelfinavir mesylate, the active pharmaceutical ingredient of Viracept. "( Trace determination of ethyl methanesulfonate in Viracept 250 mg tablets by gas chromatography-mass spectrometry.
Bonnet, PA; Civade, C; Gimeno, P; Levaillant, D; Maggio, AF; Rebiere, H; Tissier, MH, 2008
)
2.1
"Ethyl methanesulfonate (EMS) is a monofunctional ethylating agent that has been found to be mutagenic in a wide variety of genetic test systems from viruses to mammals. "( A review of the genetic effects of ethyl methanesulfonate.
Sega, GA,
)
1.85

Actions

ExcerptReferenceRelevance
"Ethyl methanesulfonate failed to increase the frequency of revertants for cell lines with mutant gpt genes carrying GC----AT transitions or AT----TA transversions, whereas it increased the frequency 50-fold to greater than 800-fold for cell lines with mutant gpt genes carrying AT----GC transitions and for one cell line with a GC----CG transversion."( Molecular analysis of ethyl methanesulfonate-induced reversion of a chromosomally integrated mutant shuttle vector gene in mammalian cells.
Davidson, RL; Greenspan, JA; Xu, FM, 1988
)
1.31

Treatment

Ethyl methanesulfonate (EMS)-treated cells were hit by 00-fixations in a dose dependent manner. The probability for fixation of lethal mutations was found equally high for cells of the first and second post treatment generation. The beta Fc gamma R gene was remethylated and the corresponding transcript was no more detectable.

ExcerptReferenceRelevance
"Ethyl methanesulfonate (EMS)-treated cells were hit by 00-fixations in a dose dependent manner; 0-fixations were not detected for any dose of EMS applied; the probability for fixation of lethal mutations was found equally high for cells of the first and second post treatment generation and, unexpectedly, was well above control in the third post-treatment generation."( Pedigree analyses of yeast cells recovering from DNA damage allow assignment of lethal events to individual post-treatment generations.
Karwan, A; Klein, F; Wintersberger, U, 1990
)
1
"In ethyl methanesulfonate-treated cells, the beta Fc gamma R gene was remethylated and the corresponding transcript was no more detectable."( Methylation in the 5' region of the murine beta Fc gamma R gene regulates the expression of Fc gamma receptor II.
Amigorena, S; Bonnerot, C; Daëron, M; Even, J; Fridman, WH; Hogarth, PM; Varin, N, 1988
)
0.79
"Untreated and ethyl methanesulfonate treated cells (K562 human erythroleukemia cell line) were used as negative and positive internal standards, respectively, in each electrophoresis run."( Validation and implementation of an internal standard in comet assay analysis.
De Boeck, M; De Visscher, G; Kirsch-Volders, M; Touil, N; Vande, PA, 2000
)
0.65
"Upon treatment with ethyl methanesulfonate (EMS), X-rays or ultraviolet (UV) light it increases in a dose-dependent fashion."( Autoradiographic detection of mutation to exotoxin-A resistance in mouse fibroblasts treated with ethyl methanesulfonate, X-rays and ultraviolet light.
Ronen, A; Tiah, M, 1989
)
0.81

Toxicity

3-Aminobenzamide is a potent inhibitor of nuclear poly ADP-ribosyl synthetase. It was tested for its ability to alter the toxic and/or transforming effects of ethyl methanesulfonate, methyl methanes sulfonate and 3-methylcholanthrene.

ExcerptReferenceRelevance
" Delays in the transit through S-phase were evident 4 hours after exposure to toxic concentrations of either carcinogen and by 8 to 12 hours post-exposure at the lower concentrations."( Flow cytometric evaluation of cell-cycle progression in ethyl methanesulfonate and methyl methanesulfonate-exposed P3 cells: relationship to the induction of sister-chromatid exchanges and cellular toxicity.
Casciano, DA; Domon, OE; Kodell, RL; McGarrity, LJ; Morris, SM, 1991
)
0.53
"Rat and canine hepatocyte suspensions were exposed to toxic concentrations of ethyl methanesulfonate (EMS) and ionophore A-23187 in the presence and absence of extracellular calcium (Ca2+) and alpha-tocopheryl succinate (alpha-TS)."( Alpha-tocopheryl succinate protects hepatocytes from chemical-induced toxicity under physiological calcium conditions.
Fariss, MW; Merson, MH; O'Hara, TM, 1989
)
0.51
" Qualitatively, the patterns of embryo malformations reported in treated embryos paralleled those observed in in vivo studies, especially in regard to adverse effects on central nervous system and craniofacial systems."( In vitro developmental toxicity of five direct-acting alkylating agents in rodent embryos: structure-activity patterns.
Faustman, EM; Gage, D; Kirby, Z; Varnum, M, 1989
)
0.28
" These data indicate that the dibutyl phthalate separation technique offers the advantage of monitoring only viable hepatocytes for changes in membrane integrity or metabolic performance during a toxic chemical insult."( Mechanism of chemical-induced toxicity. I. Use of a rapid centrifugation technique for the separation of viable and nonviable hepatocytes.
Brown, MK; Fariss, MW; Reed, DJ; Schmitz, JA, 1985
)
0.27
"3-Aminobenzamide, a potent inhibitor of nuclear poly ADP-ribosyl synthetase, was tested for its ability to alter the toxic and/or transforming effects of ethyl methanesulfonate, methyl methanesulfonate and 3-methylcholanthrene in BALB/3T3 clone A31-1 cells."( Effect of 3-aminobenzamide on the induction of toxicity and transformation by ethyl methanesulfonate and methylcholanthrene in BALB/3T3 cells.
Lubet, RA; McCarvill, JT; Putman, DL; Schechtman, LM; Schwartz, JL, 1984
)
0.69
" Furthermore, a "virtually safe dose" was established by means of the NOAEL risk factor approach (e."( Embryotoxicity induced by alkylating agents: 7. Low dose prenatal-toxic risk estimation based on NOAEL risk factor approach, dose-response relationships, and DNA adducts using methylnitrosourea as a model compound.
Bochert, G; Meister, R; Neubert, D; Platzek, T, 1993
)
0.29
"Previous studies from our laboratory have demonstrated that the administration of alpha-tocopheryl hemisuccinate (TS), but not unesterified alpha-tocopherol (T), protects hepatocytes from a variety of toxic insults including chemicals, drugs, metals, and oxidative stress."( Role of cellular energy status in tocopheryl hemisuccinate cytoprotection against ethyl methanesulfonate-induced toxicity.
Fariss, MW; Ray, SD, 1994
)
0.51
" For comparison a "virtually safe dose" was calculated by use of the no-observed-adverse-effect-level (NOAEL) risk factor approach."( Embryotoxicity induced by alkylating agents: 9. Low dose prenatal-toxic risk estimation of ethylmethanesulfonate based on no-observed-adverse-effect-level risk factor approach, dose-response relationships, and molecular dosimetry.
Bochert, G; Meister, R; Platzek, T, 1995
)
0.29
", no adverse effect level (NOAEL) and lowest observed adverse effect level (LAOEL)."( Embryotoxicity induced by alkylating agents: 10. Analysis of the combined teratogenic effects of methylnitrosourea and ethylmethanesulfonate in mice.
Bochert, G; Platzek, T, 1995
)
0.29
" Pretreatment of hepatocytes with medium deficient in sulfur amino acids accelerated cell death induced by EMS, confirming the previously reported cytoprotective role for GSH in this toxic event."( Role of cellular thiol status in tocopheryl hemisuccinate cytoprotection against ethyl methanesulfonate-induced toxicity.
Bryson, KF; Fariss, MW; Tirmenstein, MA, 1997
)
0.52
"1 mM, cadmium chloride 10(-5) M and atrazine 10(-4) M, which were weakly toxic after 2 h, became highly toxic after 48 h of contact."( Evaluation of the toxicity of chemical compounds using digestive acini of the bivalve mollusc Pecten maximus L. maintained alive in vitro.
Le Pennec, G; Le Pennec, M, 2001
)
0.31
" On the basis of a wide variety of toxicological data including critical experiments for mutation induction under chronic exposure conditions and cross-species exposure scaling experiments to extrapolate to humans, we estimate the added risk of adverse effects (cancer, birth abnormalities, heritable defects) in any individual patient accidentally exposed to EMS via contaminated Viracept tablets in the context of this production accident as essentially zero."( Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Gocke, E; Lavé, T; Müller, L; Pfister, T, 2009
)
1.8
" In order to assess further their toxic effects to target and non-target insect species, an evaluation was made of their insecticidal profile on Bactrocera oleae (Rossi) and Drosophila melanogaster (Meig."( Evaluation of toxicity and genotoxic effects of spinosad and deltamethrin in Drosophila melanogaster and Bactrocera oleae.
Akmoutsou, P; Frantzios, G; Kounatidis, I; Mademtzoglou, D; Mavragani-Tsipidou, P; Nakou, I; Onoufriadis, A; Papadakis, G; Papadopoulos, NT; Papadopoulou, X; Vasiliadis, K, 2011
)
0.37
"There is considerable evidence that genetic damage in organisms occurs in the environment as a result of exposure to genotoxins and ionising radiation, but we have limited understanding of the extent to which this results in adverse consequences at a population level."( Effects of genotoxicity and its consequences at the population level in sexual and asexual Artemia assessed by analysis of inter-simple sequence repeats (ISSR).
Grant, A; Sukumaran, S, 2013
)
0.39

Pharmacokinetics

ExcerptReferenceRelevance
" As a result of the species differences in clearance, the half-life ranged from 10 min in mouse (at low dose) to 5h in monkey."( In vivo and in vitro characterization of ethyl methanesulfonate pharmacokinetics in animals and in human.
Birnböck, H; Götschi, A; Lavé, T; Pähler, A; Ramp, T, 2009
)
0.62

Compound-Compound Interactions

ExcerptReferenceRelevance
" This cell line was used in combination with a shuttle vector, containing the bacterial lacZ' gene as reporter gene, to study mutagenicity."( A NIH/3T3 cell line stably expressing human cytochrome P450-3A4 used in combination with a lacZ' shuttle vector to study mutagenicity.
De Groene, EM; Horbach, GJ; Seinen, W, 1995
)
0.29

Bioavailability

ExcerptReferenceRelevance
" EMS was well absorbed and exhibited close to 100% oral bioavailability."( In vivo and in vitro characterization of ethyl methanesulfonate pharmacokinetics in animals and in human.
Birnböck, H; Götschi, A; Lavé, T; Pähler, A; Ramp, T, 2009
)
0.62

Dosage Studied

Methyl methanesulfonate (MMS) and ethyl methane sulfonate have shown to exhibit a nonlinear or even "thresholded" dose-response in vitro and in vivo. Treatment of folate-replete or deficient WTK1 and TK6 cells with increasing concentrations (0-50microg/ml) resulted in significantly different HPRT mutation dose- response relationships.

ExcerptRelevanceReference
" The dose-response relationship of these agents does not appear to deviate from linearity; this permits the calculation of mutation rate per unit dose."( Linear dose--response relationships after prolonged expression times in V-79 Chinese hamster cells.
Simons, JW; Van Zeeland, AA, 1976
)
0.26
" One interpretation of the linear dose-response is that, as a result of EMS treatment, ethylation of cellular constituents occurs, which is directly responsible for the mutation."( The dose-response relationship for ethyl methanesulfonate-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in Chinese hamster ovary cells.
Brimer, PA; Gosslee, DG; Hsie, AW; Mitchell, TJ, 1975
)
0.53
" Using a 2--h treatment time, we observed a linear dose-response relationship up to 250 mg of DMN per kg body weight."( Mutagenicity of dimethylnitrosamine and ethyl methanesulfonate as determined by the host-mediated CHO/HGPRT assay.
Couch, DB; Holland, JM; Hsie, AW; Machanoff, R, 1978
)
0.53
" In general the magnitude of this induced variation increased with increasing dosage of the mutagen."( Induced quantitative variation for penicillin titre in clonal populations of Aspergillus nidulans.
Caten, CE; Simpson, IN, 1979
)
0.26
" Previous reports that caffeine enhances induced mutation frequencies are explained by an artefact in the situ method used; a similar artefact may also explain the cumulative in situ mutation dose-response curves."( Failure of caffeine to influence induced mutation frequencies and the independence of cell killing and mutation induction in V79 Chinese hamster cells.
Fox, M; McMillan, S, 1979
)
0.26
" The lack of effect was not due to the insensitivity of the system used, since both the VC and VDC study a mutagenic effect was clearly demonstrated in male mice dosed IP with the positive control compounds cyclophosphamide (CTX) and/or ethylmethane sulfonate (EMS)."( Dominant lethal studies with the halogenated olefins vinyl chloride and vinylidene dichloride in male CD-1 mice.
Anderson, D; Hodge, MC; Purchase, IF, 1977
)
0.26
" These predictions were in reasonably good agreement with the observed dose-response data for these agents."( Alkylation of deoxyribonucleic acid in vivo in various organs of C57BL mice by the carcinogens N-methyl-N-nitrosourea, N-ethyl-N-nitrosourea and ethyl methanesulphonate in relation to induction of thymic lymphoma. Some applications of high-pressure liquid
Frei, JV; Lawley, PD; Swenson, DH; Warren, W, 1978
)
0.26
" Mutational dose-response studies with X-rays, ethyl methanesulfonate (EMS), and ICR-191 were conducted in 4 of these revertant cell lines."( Heritable alterations at the adenine phosphoribosyltransferase (APRT) locus in human lymphoblastoid cell lines.
Amundson, SA; Fortunato, JE; Liber, HL, 1992
)
0.54
" The parental cells exhibited biphasic dose-response curves in accordance with the idea of low basal level saturation attributed to the uninducible ogt ATase."( Mutagenesis and DNA repair for alkylation damages in Escherichia coli K-12.
Abril, N; Prieto-Alamo, MJ; Pueyo, C; Roldán-Arjona, T; van Zeeland, AA, 1992
)
0.28
" The slopes of the dose-response curves differed by approximately 10-fold for mutation of the two alleles and this relationship held true for several independently isolated cell lines."( A comparison of induced mutation at homologous alleles of the tk locus in human cells.
Amundson, SA; Liber, HL, 1991
)
0.28
" Contrary to what happens with mutations at the LS group, mutations at the bc group do not affect sex determination, nor late dosage compensation nor oogenesis."( Genetic and molecular analysis of new female-specific lethal mutations at the gene Sxl of Drosophila melanogaster.
Bachiller, D; Barbero, JL; Granadino, B; Sánchez, L; Torres, M; Torroja, E, 1991
)
0.28
" To determine the importance in germ-line mutagenesis of the O6-G site relative to the N-7 of guanine, dose-response curves were constructed for both ENU and EMS, where dose was measured as total adducts per deoxynucleotide (APdN) and response as sex-linked recessive lethals (SLRL) induced in Drosophila melanogaster spermatozoa."( Comparison of dose-response relationships for ethyl methanesulfonate and 1-ethyl-1-nitrosourea in Drosophila melanogaster spermatozoa.
Beranek, DT; Byrne, BJ; Lee, WR; Tucker, AB, 1990
)
0.54
" EMS was examined in the absence of any exogenous metabolic activation system, and the mutagenic dose-response obtained served to calibrate the assay."( Mutation assays of ethyl methanesulphonate, benzidine and benzo[a]pyrene using Chinese hamster V79 cells.
O'Donovan, MR, 1990
)
0.28
" The test relies on a gene dosage selection system in which hyperploidy is detected by the simultaneous increase in copy number of two alleles residing on the right arm of chromosome VIII: arg4-8 and cup1S (Rockmill and Fogel."( The detection of mitotic and meiotic chromosome gain in the yeast Saccharomyces cerevisiae: effects of methyl benzimidazol-2-yl carbamate, methyl methanesulfonate, ethyl methanesulfonate, dimethyl sulfoxide, propionitrile and cyclophosphamide monohydrate.
Fogel, S; Maloney, DH; Moser, SF; Piegorsch, WW; Resnick, MA; Whittaker, SG, 1990
)
0.48
" These contradictory results are caused, on the one hand, by the very steep dose-response curve after hypotonic treatment and on the other hand by the varying degree of cell-cycle delay after combination treatment."( The use of multiple sampling times in in vitro chromosome assays.
Nowak, C, 1990
)
0.28
" The induction frequency per viable cell appears to be dose dependent for these four types of radiation, and the dose-response curves are approximately linear."( Induction of proline prototrophs in CHO-K1 cells by heavy ions.
Craise, LM; Mei, MT; Yang, TC, 1986
)
0.27
" Comparison to chromosome-aberration studies demonstrates the suitability of this method to screen quickly for adequate dosing of a cytotoxic substance and also gives information on the appropriate preparation interval."( Flow-cytometric cell-cycle analysis of Chinese hamster cells following exposure to cytotoxicants.
Fertig, G; Miltenburger, HG, 1989
)
0.28
" In addition, a dose-response curve was established for eight concentrations of benzo[alpha]pyrene."( The micronucleus test in Xenopus: a new and simple 'in vivo' technique for detection of mutagens in fresh water.
Jaylet, A; Kirsch-Volders, M; Paulussen, J; Van Hummelen, P; Zoll, C, 1989
)
0.28
" For both compounds, very similar dose-response curves were found for induction of chromatid breaks in the dose range 10-75 mg/kg."( Transplacental genetic and cytogenetic effects of alkylating agents in the mouse. II. Induction of chromosomal aberrations.
Braun, R; Hüttner, E; Schöneich, J, 1986
)
0.27
" In order to evaluate potentially small complementation or dosage effects, mutant stains were made coisogenic for 3R."( Molybdenum hydroxylases in Drosophila. III. Further characterization of the low xanthine dehydrogenase gene.
Baldwin, MC; Finnerty, V; Schott, DR, 1986
)
0.27
" The dose-response relationship between the frequency of sex-linked recessive lethals and the estimated absorbed dose showed no deviation from linearity at all the five absorbed doses tested."( Linear relationship between lethal mutation yield and intake of ethyl methanesulfonate in Drosophila melanogaster.
Ayaki, T; Oshima, K; Yoshikawa, I, 1985
)
0.51
" At the maximal effect, during week 3 (days 15-19 post-EMS), a dosage of 50 mg/kg caused 13."( Germ-cell mutagenesis and GSH depression in reproductive tissue of the F-344 rat induced by ethyl methanesulfonate.
Bishop, JB; Harbison, RD; Teaf, CM, 1985
)
0.49
" The frequency of TGr mutations increased linearly with the number of EMS treatments whereas the yield of BrdUrdr mutations showed a curvilinear dose-response curve."( Mutations resistant to bromodeoxyuridine in mouse lymphoma cells selected by repeated exposure to EMS. Characteristics of phenotypic instability and reversion to HAT resistance by 5-azacytidine.
Nakamura, N; Okada, S, 1983
)
0.27
" However, with a fixed experimental regimen, treatments with relatively higher doses cause a deformity of the dose-response relationship."( Proliferative kinetics and chemical-induced sister chromatid exchanges in human lymphocyte cultures.
Morimoto, K, 1984
)
0.27
" For biological effects with a linear dose-response relationship, this demonstrates the validity of hemoglobin alkylation as an indicator of the risk."( Relationships between ethylation of hemoglobin, ethylation of DNA and administered amount of ethyl methanesulfonate in the mouse.
Calleman, CJ; Murthy, MS; Osterman-Golkar, S; Segerbäck, D; Svensson, K, 1984
)
0.49
" While a dose-dependent increase in SCE was obtained for both procarcinogens at each age, the mean SCE frequency was significantly higher in the 6-day embryos for each dosage given."( Differential induction of sister chromatid exchanges by indirect-acting mutagen-carcinogens at early and late stages of embryonic development.
Bloom, SE; Todd, LA, 1980
)
0.26
"Groups of male Alderly Park mice of proven fertility were dosed by gavage for 5 consecutive days per week for 8 weeks or 5 consecutive days only with 100 or 150 mg/kg body weight ethyl methanesulphonate (EMS) or by intraperitoneal injection once a week for 8 weeks or once only with 500 mg/kg shikimic acid."( Comparison of dominant lethal and heritable translocation methodologies.
Anderson, D; Hodge, MC; Palmer, S; Purchase, IF, 1981
)
0.26
"The shape of the dose-response curve for mutations induced at low doses of mutagenic agents in mammalian cells was studied."( Relationship between chemical damage of DNA and mutations in mammalian cells. I. Dose-response curves for the induction of 6-thioguanine-resistant mutants by low doses of monofunctional alkylating agents, X-rays and UV radiation in V79 Chinese hamster cel
Jenssen, D; Ramel, C, 1980
)
0.26
" On replating in graded NaCl, a family of dose-response curves is obtained, rising in level of resistance according to the degree of hypertonicity used to isolate the variants initially."( Osmotic stress variants in Chinese hamster cells.
Harris, M, 1993
)
0.29
" EMS doses of 100 or 200 mM (Ogt+) and of 50 mM (Ogt-) were selected from the corresponding dose-response curves for DNA sequence analysis."( DNA repair by Ogt alkyltransferase influences EMS mutational specificity.
Abril, N; Pueyo, C; Vidal, A, 1995
)
0.29
" Exposure to EMS or effluent resulted in statistically significant increases in micronucleus frequency and there was a positive dose-response effect over the entire dose range."( Genotoxic effects of two industrial effluents and ethyl methane sulfonate in Clarias lazera.
Odeigah, PG; Osanyinpeju, AO; Osanyipeju, AO, 1995
)
0.29
"1 mg/kg body wt MNU) as well as extrapolation by probit analysis based on a dose-response study (estimated ED0."( Embryotoxicity induced by alkylating agents: 7. Low dose prenatal-toxic risk estimation based on NOAEL risk factor approach, dose-response relationships, and DNA adducts using methylnitrosourea as a model compound.
Bochert, G; Meister, R; Neubert, D; Platzek, T, 1993
)
0.29
" Furthermore, derived from a dose-response study of teratogenicity extrapolation to the possible risk of low doses was performed using nonlinear mathematical models."( Embryotoxicity induced by alkylating agents: 9. Low dose prenatal-toxic risk estimation of ethylmethanesulfonate based on no-observed-adverse-effect-level risk factor approach, dose-response relationships, and molecular dosimetry.
Bochert, G; Meister, R; Platzek, T, 1995
)
0.29
"In previous studies the direct-acting alkylating model compounds methylnitrosourea (MNU) and ethylmethanesulfonate (EMS) were investigated with regard to dose-response of teratogenicity as well as DNA adduct formation in mice."( Embryotoxicity induced by alkylating agents: 10. Analysis of the combined teratogenic effects of methylnitrosourea and ethylmethanesulfonate in mice.
Bochert, G; Platzek, T, 1995
)
0.29
" In the small intestine, treatment with various dosages of ENU (10-150 mg/kg) resulted in a linear dose-response in both lacZ and Dlb-I."( Gene-mutation assays in lambda lacZ transgenic mice: comparison of lacZ with endogenous genes in splenocytes and small intestinal epithelium.
Baan, RA; Bergmans, A; Howard, L; Tates, AD; van Dam, FJ; van Delft, JH; Winton, DJ, 1998
)
0.3
" Previously, large-scale dose-response studies on teratogenicity as well as on DNA modification were performed using these substances."( DNA alkylation studies of combined treatment with methylnitrosourea and ethylmethanesulfonate in mice.
Bochert, G; Platzek, T, 2000
)
0.31
" Rats were treated with saline or one of three genotoxic agents (6-mercaptopurine, ethyl methanesulfonate or propane sultone) in an acute dosing protocol."( Enumeration of micronucleated reticulocytes in rat peripheral blood: a flow cytometric study.
Dertinger, SD; Hall, NE; Tometsko, CR; Torous, DK, 2000
)
0.53
" We found that the ro(Dom) stop-furrow phenotype was sensitive to the dosage of genes known to affect retinal differentiation, in particular members of the hedgehog (hh) signaling cascade."( A screen for dominant modifiers of ro(Dom), a mutation that disrupts morphogenetic furrow progression in Drosophila, identifies groucho and hairless as regulators of atonal expression.
Chanut, F; Heberlein, U; Luk, A, 2000
)
0.31
" Treatment of folate-replete or deficient WTK1 and TK6 cells with increasing concentrations (0-50microg/ml) of ethyl methanesulfonate (EMS) resulted in significantly different HPRT mutation dose-response relationships (P<0."( The effect of folate deficiency on the cytotoxic and mutagenic responses to ethyl methanesulfonate in human lymphoblastoid cell lines that differ in p53 status.
Branda, RF; Brooks, EM; Nicklas, JA; O'Neill, JP; Trombley, LM, 2001
)
0.75
" A rapid increase of GST activities was observed within 24 h with all compounds tested, and a time- as well as a dose-response was established."( Induction of glutathione-S-transferases in primary cultured digestive gland acini from the mollusk bivalve Pecten maximus (L.): application of a new cellular model in biomonitoring studies.
Le Pennec, G; Le Pennec, M, 2003
)
0.32
" Spontaneous and chemical-induced recombination frequencies (RF) were measured in a series of time-course and dose-response experiments with direct-acting mutagens."( Direct detection of deletion mutations in the yeast DEL assay using quantitative PCR (TaqMan).
Cise, L; Li, B; Watson, D, 2003
)
0.32
" All the three doses of both VC and BC appeared to reduce the EMS-induced genotoxicity in this fish to a variable extent, of which the higher dose of VC appeared to give marginally better protection while the dose-response relationship was inconclusive for BC."( Ameliorative effects of vitamin supplementation on ethyl methane sulphonate-induced genotoxicity in a fish, Anabas testudineus.
Das, JK; Guha, B; Khuda-Bukhsh, AR, 2007
)
0.34
" In contrast, alkylation-induced DNA damage was detectable even after 72 days of recovery in de-chlorinated water, with a dose-response relationship observable throughout the whole recovery period."( Persistence of DNA damage in the freshwater mussel Unio pictorum upon exposure to ethyl methanesulphonate and hydrogen peroxide.
Klobucsar, GI; Malović, L; Pavlica, M; Stambuk, A, 2008
)
0.35
" 67 (2007) 3904-3911] provided evidence, however, that the dose-response curve for mutagenic and clastogenic activity of EMS was thresholded - in contrast to ethylnitrosourea (ENU) tested in parallel."( In vivo studies in the mouse to define a threshold for the genotoxicity of EMS and ENU.
Gocke, E; Müller, L, 2009
)
0.35
" Doses up to 80mg/kg/day (7-day dosing regime) did not induce micronuclei in mouse bone marrow."( MNT and MutaMouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU.
Ballantyne, M; Gocke, E; Müller, L; Whitwell, J, 2009
)
0.35
" In the first four papers, the course of events and the toxicological information available at the outset are summarized and a traditional cancer risk assessment on the basis of a linear default dose-response is made."( The Viracept (nelfinavir)--ethyl methanesulfonate case: a threshold risk assessment for human exposure to a genotoxic drug contamination?
Lutz, WK, 2009
)
0.65
" Prior to starting our investigations we searched the literature for toxicity data on this well established mutagen with specific attention to dose-response relations in in vivo genotoxicity studies, since, obviously, in vivo data are pivotal for risk assessment."( Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate.
Bürgin, H; Gocke, E; Müller, L; Pfister, T, 2009
)
0.58
" It also presents an outlook on the nature of additional research building upon the Viracept-EMS case to test assumptions underlying thresholded dose-response relationships and to establish biologically based risk assessment models in lieu of default models for DNA-reactive compounds."( The Viracept-EMS case: impact and outlook.
Casciano, DA; Tweats, DJ; Walker, VE, 2009
)
0.35
"In recent years, experimental evidence has accumulated that supports the existence of sublinear dose-response relationships at low doses of DNA reactive mutagens."( Defining EMS and ENU dose-response relationships using the Pig-a mutation assay in rats.
Cammerer, Z; Coffing, SL; Dobo, KL; Fiedler, RD; Gunther, WC; Schuler, M; Shutsky, T; Thiffeault, CJ, 2011
)
0.37
" To compare data obtained from frozen tissues to data from freshly isolated tissues, we conducted a dose-response study in male Sprague Dawley rats."( Comparison of Comet assay dose-response for ethyl methanesulfonate using freshly prepared versus cryopreserved tissues.
Hobbs, CA; Kissling, GE; Recio, L; Witt, KL, 2012
)
0.64
"Mutagenic and clastogenic effects of some DNA damaging agents such as methyl methanesulfonate (MMS) and ethyl methanesulfonate (EMS) have been demonstrated to exhibit a nonlinear or even "thresholded" dose-response in vitro and in vivo."( Quantitative assessment of the dose-response of alkylating agents in DNA repair proficient and deficient ames tester strains.
Guérard, M; Tang, L; Zeller, A, 2014
)
0.64
" As a continuation of our earlier report that analyzed ethyl methanesulfonate (EMS) and methyl methanesulfonate (MMS) dose-response data (Gollapudi et al."( Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment.
Abraham, L; Bodger, OG; Dearfield, KL; Gollapudi, BB; Heflich, RH; Hixon, JG; Johnson, GE; Lovell, DP; MacGregor, JT; Pottenger, LH; Soeteman-Hernández, LG; Tanir, JY; Thompson, CM; Thybaud, V; van Benthem, J; White, PA; Zeiger, E, 2014
)
0.65
" Three dose levels of EMS (180, 360, and 720mg/kg) were administered once by oral gavage to 8-week-old male Crl:CD(SD) rats, and peripheral blood was sampled at 0 (1 day before dosing), 1, 2, and 4 weeks after dosing with EMS."( PIGRET assay can detect mutagenicity of ethyl methanesulfonate much earlier than RBC Pig-a assay.
Hanamoto, A; Hattori, C; Itoh, S; Nakayama, S, 2016
)
0.7
"There is growing interest in quantitative analysis of in vivo genetic toxicity dose-response data, and use of point-of-departure (PoD) metrics such as the benchmark dose (BMD) for human health risk assessment (HHRA)."( Comparing BMD-derived genotoxic potency estimations across variants of the transgenic rodent gene mutation assay.
Battaion, HL; Johnson, GE; Slob, W; White, PA; Wills, JW, 2017
)
0.46
" In the present article, described are the methods for development of a good TILLING population, including preparation of the dosage curve, mutagenesis and maintenance of the mutant population, and screening of the mutant population using the PCR-based Cel-1 assay."( Development of Targeting Induced Local Lesions IN Genomes (TILLING) Populations in Small Grain Crops by Ethyl Methanesulfonate Mutagenesis.
Chhabra, B; Mahlandt, A; Rawat, N; Schoen, A; Singh, L; Steadham, J; Tiwari, V, 2019
)
0.73
"In order to investigate the possibility that treatment age affects the genotoxic response to ethyl methane sulfonate (EMS) exposure, we dosed gpt-delta neonatal mice on postnatal days 1-28 with 5-100 mg/kg/day of EMS and measured micronucleus (MN) induction in peripheral blood and gpt gene mutation in liver, lung, bone marrow, small intestine, spleen, and kidney."( Effect of life stage and target tissue on dose-response assessment of ethyl methane sulfonate-induced genotoxicity.
Cao, X; Dad, A; Heflich, RH; Mittelstaedt, RA; Pearce, MG, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (6)

RoleDescription
alkylating agentHighly reactive chemical that introduces alkyl radicals into biologically active molecules and thereby prevents their proper functioning. It could be used as an antineoplastic agent, but it might be very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. It could also be used as a component of poison gases.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
genotoxinA role played by a chemical compound to induce direct or indirect DNA damage. Such damage can potentially lead to the formation of a malignant tumour, but DNA damage does not lead inevitably to the creation of cancerous cells.
mutagenAn agent that increases the frequency of mutations above the normal background level, usually by interacting directly with DNA and causing it damage, including base substitution.
teratogenic agentA role played by a chemical compound in biological systems with adverse consequences in embryo developments, leading to birth defects, embryo death or altered development, growth retardation and functional defect.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
methanesulfonate esterAn organosulfonic ester resulting from the formal condensation of methanesulfonic acid with the hydroxy group of an alcohol, phenol, heteroarenol, or enol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
interleukin 8Homo sapiens (human)Potency74.97800.047349.480674.9780AID651758
thioredoxin reductaseRattus norvegicus (Norway rat)Potency100.00000.100020.879379.4328AID588453
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.63410.006038.004119,952.5996AID1159521; AID1159523
retinoid X nuclear receptor alphaHomo sapiens (human)Potency22.30130.000817.505159.3239AID1159527
chromobox protein homolog 1Homo sapiens (human)Potency70.79460.006026.168889.1251AID540317
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency100.00000.050127.073689.1251AID588590
gemininHomo sapiens (human)Potency9.20000.004611.374133.4983AID624296
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (20)

Assay IDTitleYearJournalArticle
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID229742Hypersensitivity factor (HF) of IC50 (AA8) / IC50 (UV-4) of compound for repair deffective mutants1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives.
AID229741Hypersensitivity factor (HF) of IC50 (AA8) / IC50 (EM-9) of compound for repair deffective mutants1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives.
AID746711Genotoxicity in human HepG2/C3A cells assessed as DNA fragmentation at 0.5 mM after 24 hrs by alkaline comet assay (Rvb = 6.65%)2013European journal of medicinal chemistry, May, Volume: 63Biological evaluation of bisbenzaldehydes against four Mycobacterium species.
AID45745Inhibitory activity of compound for AA8 cells to reduce cell density by 50% (exposed to compound for 4 hours)1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives.
AID746710Genotoxicity in human HepG2/C3A cells assessed as DNA fragmentation at 0.75 mM after 24 hrs by alkaline comet assay (Rvb = 6.65%)2013European journal of medicinal chemistry, May, Volume: 63Biological evaluation of bisbenzaldehydes against four Mycobacterium species.
AID1111854Genotoxicity in Drosophila melanogaster larvae at 10'-3 M2011Pest management science, Dec, Volume: 67, Issue:12
Evaluation of toxicity and genotoxic effects of spinosad and deltamethrin in Drosophila melanogaster and Bactrocera oleae.
AID229743Hypersensitivity factor (HF) of IC50 (AA8) / IC50 (UV-5) of compound for repair deffective mutants1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
Hypoxia-selective antitumor agents. 2. Electronic effects of 4-substituents on the mechanisms of cytotoxicity and metabolic stability of nitracrine derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,963)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990757 (38.56)18.7374
1990's451 (22.98)18.2507
2000's419 (21.34)29.6817
2010's272 (13.86)24.3611
2020's64 (3.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.86

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.86 (24.57)
Research Supply Index7.61 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index88.78 (26.88)
Search Engine Supply Index2.02 (0.95)

This Compound (51.86)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (0.20%)5.53%
Reviews23 (1.14%)6.00%
Case Studies1 (0.05%)4.05%
Observational0 (0.00%)0.25%
Other1,989 (98.61%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]